Replies to post #1008 on Cyclacel Pharmaceutical Inc (CYCC)

[ou71764]

LOL! At least on IHUB you have to be a kinder, gentler sort.

CYCC seems to be in a trading range - pick your own numbers depending on what variables you use - but I'd say mostly in the 1.60's. We need news.

My concern is that the NSCLC results won't be as good as I want. If so, I doubt that it will hurt all that much because expectations are pretty low right now. I can't see any news taking much below the the 1.40's.

But the NSCLC news could send us much, much higher. So, the risk /reward is still favorable IMO. And for long term investors (2-3 years out) it's clearly favorable. We could even withstand another dilution as big as the last one and still see the stock in the teens by 2013. That is, assuming sapacitabine gets approved, as I think it will.

Right now I'd say the stock is for gamblers or long term investors. But hey, that's probably true most of the time for most stocks!